Main > GASTROENTEROLOGY > Crohn's Disease > Treatment > Co.: USA. J. UstekinuMAb

---

Co.: USA. J. UstekinuMAb's subsections
(*) CA Approval Date: 2016. 12.14
(*) USA Approval Date: 2016. 09.26
Company
Mechanism: IL-12 & IL-23 Inhibition
TradeMark
TradeMark Web-Site

Co.: USA. J. UstekinuMAb's products
This section has no products